Related Experiment Video

Updated: Oct 2, 2026

Lighting Up the Pathways to Caspase Activation Using Bimolecular Fluorescence Complementation
08:47

Lighting Up the Pathways to Caspase Activation Using Bimolecular Fluorescence Complementation

Published on: March 5, 2018

A cellular mechanism that reversibly inactivates pancaspase inhibitor zAsp-CH(2)-DCB: a potential pitfall causing

Kaori Sakurada1, Chifumi Kitanaka, Akiko Kokubu

  • 1Biophysics Division, National Cancer Center Research Institute, 5-1-1 Tsukiji, Chuo-ku, Tokyo 104-0045, Japan.

Biochemical and Biophysical Research Communications
|February 28, 2002
PubMed

Insights

The caspase inhibitor zAsp-CH2-DCB is unexpectedly inactivated by cells, limiting its effectiveness in apoptosis studies. This cellular mechanism requires protein synthesis and affects caspase inhibitor experimental design.

Area of Science:

  • Biochemistry
  • Cell Biology
  • Pharmacology

Background:

  • Caspase inhibitors are crucial tools for studying apoptosis.
  • zVAD-fmk and zAsp-CH2-DCB are common pancaspase inhibitors.
  • Their efficacy in cellular models requires careful validation.

Purpose of the Study:

  • To investigate the differential effects of zVAD-fmk and zAsp-CH2-DCB on staurosporine-induced neuroblastoma cell death.
  • To elucidate the mechanism behind the observed discrepancies in caspase inhibition.
  • To highlight implications for experimental design using caspase inhibitors.

Main Methods:

  • Treatment of neuroblastoma cells with staurosporine (STS) and caspase inhibitors (zVAD-fmk, zAsp-CH2-DCB).
  • Time course analysis of apoptosis and caspase substrate processing.
  • In vitro caspase activity assays on cell lysates.
  • Investigation of the cellular mechanism of zAsp-CH2-DCB inactivation.

Main Results:

  • zVAD-fmk consistently inhibited apoptosis and substrate processing.
  • zAsp-CH2-DCB showed transient inhibition of substrate processing in intact cells.
  • In vitro assays revealed complete inhibition of caspase activity by zAsp-CH2-DCB.
  • A reversible, protein synthesis-dependent cellular mechanism inactivates zAsp-CH2-DCB.

Conclusions:

  • zAsp-CH2-DCB efficacy is limited by a reversible intracellular inactivation process.
  • This finding necessitates caution when interpreting results from experiments using zAsp-CH2-DCB.
  • Experimental design and interpretation of caspase inhibitor studies require careful consideration of cellular context.

More Related Videos

Visualization of Inflammatory Caspases Induced Proximity in Human Monocyte-Derived Macrophages08:41

Visualization of Inflammatory Caspases Induced Proximity in Human Monocyte-Derived Macrophages

Published on: April 6, 2022

Evaluation of Caspase Activation to Assess Innate Immune Cell Death10:23

Evaluation of Caspase Activation to Assess Innate Immune Cell Death

Published on: January 20, 2023

Related Concept Videos

Caspases01:24

Caspases

Caspase, a family of cysteine proteases, serve as effectors in apoptosis. The ced3 gene in C.elegans was first identified to be involved in apoptosis. This gene encodes the ced-3 caspase that is similar to the interleukin-1-beta converting enzyme or ICE in mammals. In addition to apoptosis, caspases also function in the inflammatory response. Inflammatory caspases are essential in activating pro-inflammatory cytokines that recruit immune cells and block the replication of pathogens inside cells.
The Intrinsic Apoptotic Pathway01:31

The Intrinsic Apoptotic Pathway

Internal cellular stress, such as cellular injury or hypoxia, triggers intrinsic apoptosis. The B-cell lymphoma 2 (Bcl-2) family of proteins are the primary regulators of the intrinsic apoptotic pathway. For example, during DNA damage, checkpoint proteins, such as Ataxia Telangiectasia Mutated (ATM protein) and Checkpoints Factor-2 (Chk2) proteins, are activated. These proteins phosphorylate p53 which further activates pro-apoptotic proteins, such as Bax, Bak, PUMA, and Noxa, and inhibits...
The Extrinsic Apoptotic Pathway01:17

The Extrinsic Apoptotic Pathway

The extrinsic apoptotic pathway is initiated when extracellular death-inducing signals, such as specific cytokines, activate the death receptors expressed on the cell surface. The immune cells involved in this pathway are natural killer cells (NK cells) and cytotoxic T-lymphocytes. NK cells are critical in innate immune response, while cytotoxic T-lymphocytes are associated with adaptive immune response. These cells recognize specific receptors expressed on the altered cells and activate...
Inhibition of Cdk Activity02:34

Inhibition of Cdk Activity

The orderly progression of the cell cycle depends on the activation of Cdk protein by binding to its cyclin partner. However, the cell cycle must be restricted when undergoing abnormal changes. Most cancers correlate to the deregulated cell cycle, and since Cdks are a central component of the cell cycle, Cdk inhibitors are extensively studied to develop anticancer agents. For instance, cyclin D associates with several Cdks, such as Cdk 4/6, to form an active complex. The cyclin D-Cdk4/6 complex...